Pharmaceutical Complex Zyban Rising: Smokers Thwart Insurance Carriers But Get What They Pay for By James La Rossa Jr. While the latest smoking cessation therapy utilizing the compound Zyban is making the rounds of newspapers and television news programs, its identical twin, bupropion, or Wellbutrin SR, is getting the lion’s [...]
Point & Commentary Physicians Back in the Driver’s Seat By James M. La Rossa Jr. At the beginning of 1997, the seasoned CBS newsman, Mike Wallace, and his wife Mary, sat for a portrait cover of the first Mental Fitness Consumer edition.1 Wallace’s honest disclosure about his suicidal depression was [...]
Guest Editorial A u t i s m : A Personal Insight B y T e m ple G r a n d i n , P h D W hen I wa s 3, I had a ll the sy mptoms of autism— no speech, tantrums, self-stimulatory behavior, and [...]
EDITOR’S NOTE The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry By Michael E. Thase, MD It is both an honor and a ch a llenge to assume the helm as editor of P sy ch o p h a rm ac o l [...]
2007 Edition, N. 2 ORIGINAL RESEARCH Vol. 39 No. 1 - Vol. 40, No. 1 ------------------------------------------------------------------------ IS ANTIDEPRESSANT SELECTION RATIONAL? Every clinician faces the daily question of which antidepressant is best for a particular depressed patient. Double-blind studies submitted for U.S. Federal Drug Administration marketing approval include only the “purest” [...]
2007 Edition, N. 1 ORIGINAL RESEARCH Vol. 39 No. 1 - Vol. 40, No. 1 ------------------------------------------------------------------------ DEBATING PSYCHOTROPICS AND SUICIDALITY Until now, it has been unclear if the suicide risk is significantly different among clinical trial patients assigned to psychotropic, compared with patients assigned to placebo. Researchers examine - in [...]
A Long-Revered Resource in Academia Published from 1965 until 2000 by the National Institute of Mental Health (NIMH), Psychopharmacology BULLETIN forged its path just as psychiatry itself was embarking on its golden era of treatment breakthroughs and recognition as a valid and independent field of medicine. Within months of MedWorks [...]